Page last updated: 2024-10-30

mefenamic acid and Heart Failure

mefenamic acid has been researched along with Heart Failure in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamska-Dyniewska, H1
Kowalczyk, L1
Tkaczewski, W1

Other Studies

1 other study available for mefenamic acid and Heart Failure

ArticleYear
[Mefenamic acid pharmacokinetics in patients with congestive heart failure].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1979, Jan-29, Volume: 34, Issue:5

    Topics: Aged; Biological Availability; Heart Failure; Humans; Kinetics; Mefenamic Acid; Middle Aged

1979